The value of co-creating a clinical outcome assessment strategy for clinical trial research: process and lessons learnt
Abstract Background In support of UCB pharmaceutical research programs, the aim of this research was to implement a novel process for patient involvement in a multidisciplinary research group to co-create a clinical outcome assessment strategy to accurately reflect the experience of people living wi...
Main Authors: | Thomas Morel, Karlin Schroeder, Sophie Cleanthous, John Andrejack, Geraldine Blavat, William Brooks, Lesley Gosden, Carroll Siu, Natasha Ratcliffe, Ashley F. Slagle |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | Research Involvement and Engagement |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40900-023-00505-7 |
Similar Items
-
Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson’s
by: Thomas Morel, et al.
Published: (2023-04-01) -
Correction to: The value of co-creating a clinical outcome assessment strategy for clinical trial research: process and lessons learnt
by: Thomas Morel, et al.
Published: (2024-01-01) -
“Ups and Downs, Joys and Sorrows” – Assessment and Clinical Relevance of Patient Priorities in an Interdisciplinary Parkinson’s Disease Clinic
by: Esme D. Trahair, et al.
Published: (2024-10-01) -
A Qualitative Study on Perspectives of Parkinson’s Disease Medications: Insights from Patient Focus Groups
by: Richards K, et al.
Published: (2024-09-01) -
Medication as a social prosthesis: People with Parkinson's negotiating medication
by: Terrie Vann Ward, et al.
Published: (2023-12-01)